Will gene editing unmask synthetic lethal targets?
Interviewee/Contributor
Ceri Wiggins and Jon Moore
Organisation
Horizon Discovery Group Plc
Gene therapy
How gene editing is changing the field of medicine
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Producing viral vectors on an industrial scale
Interviewee/Contributor
Nicole Faust
Organisation
CEVEC Pharmaceuticals GmbH
Developing gene therapies: a manufacturing view
Interviewee/Contributor
Madhusudan Peshwa
Organisation
GE Healthcare
Will CRISPR be safe enough for the clinic?
Interviewee/Contributor
Jonathan Moore
Chimeric antigen receptor therapy goes global
Interviewee/Contributor
Carl June
Organisation
University of Pennsylvania, Perelman School of Medicine
Cell and gene therapies pose new logistic challenges
Interviewee/Contributor
Simon Ellison
Organisation
World Courier
How genome editing is impacting cell therapy
Interviewee/Contributor
Jonathan Moore
Organisation
Horizon Discovery Group Plc
Cell therapy success and the competition for value
Interviewee/Contributor
Miguel Forte
Organisation
Zelluna Immunotherapy AS
How GMO rules affect gene and cell therapies
Interviewee/Contributor
Houria Bachtarzi
Organisation
ERA Consulting (UK) Ltd